NVE Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVEC research report →
Price Chart
About the company
NVE Corporation develops and sells devices that use spintronics, a nanotechnology relying on electron spin to acquire, store, and transmit information, both in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in sensing and transmitting data. Its products include standard sensors designed to detect the presence of magnetic or metallic materials, which help determine position, rotation, or speed in the factory automation market.
- CEO
- Peter G. Eames
- IPO
- 1995
- Employees
- 41
- HQ
- Eden Prairie, MN, US
Get TickerSpark's AI analysis on NVEC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $532.55M
- P/E
- 29.60
- PEG
- 1.23
- P/S
- 17.04
- P/B
- 8.91
- EV/EBITDA
- 24.78
- Div Yield
- 3.63%
- Gross Margin
- 79.26%
- Op Margin
- 62.07%
- Net Margin
- 57.64%
- ROE
- 30.53%
- ROIC
- 27.05%
Latest fiscal year · YoY change
- Revenue
- $26.33M+1.8%
- Gross Profit
- $20.73M-4.2%
- Op Income
- $15.92M
- Net Income
- $15.20M+0.9%
- EPS
- $3.14+0.6%
- OCF Growth
- +16.4%
- FCF Growth
- +10.8%
- 52W High
- $135.00
- 52W Low
- $57.21
- 50D MA
- $106.82
- 200D MA
- $81.26
- Beta
- 1.34
- RSI (14)
- 47
- Avg Volume
- 241.82K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
NVE reported a blowout quarter with revenue up 81% and EPS of $1.32, while management said new products, robotics demand, and a stronger semiconductor backdrop are driving momentum.· July 22, 2026
- Revenue rose 81% year over year to $11 million, led by an 82% increase in product sales and a 53% increase in contract R&D.
- Net income increased 79% to $6.39 million, or $1.32 per diluted share, with gross margin expanding to 81.3%.
- Management highlighted new wafer-level chip scale sensors for implantable medical devices, including an MRI-safe feature, and said more products are in development for robotics and power conversion.
- Robotics and automation were described as the strongest and most promising end market, with management also noting AIoT, data centers, and advanced manufacturing opportunities.
- The recent capacity expansion is now supporting R&D and some production, and management said it should benefit long-term growth as new products ramp.
First-quarter total revenue increased 81% year over year to $11 million from $6.1 million, driven by an 82% increase in product sales and a 53% increase in contract R&D revenue. Gross margin improved to 81.3% of revenue from 8.6% a year ago. Net income rose 79% to $6.39 million, or $1.32 per diluted share, from $3.8 million or $0.74 per share. Operating margin was 66%, pretax margin was 78%, and net margin was 58%. Cash plus marketable securities increased to $43.9 million from $43.5 million at March 31. Management did not provide formal next-quarter or full-year guidance, but said the quarter reflected a stronger semiconductor market, new products, and increasing momentum in robotics, and they were optimistic about the current quarter and beyond.
Dan Baker framed the quarter as exceptional and tied the results to new product sales and a strong semiconductor market. He emphasized sales and marketing investments, especially trade shows focused on sensors, robotics, AIoT, and power conversion, as well as the company’s leadership transition and board expansion. His tone was confident and celebratory, but he repeatedly avoided giving numeric forward guidance and instead pointed to long-term optimism.
Daniel Nelson focused on the financial step-up: revenue of $11 million, gross margin of 81.3%, net income of $6.39 million, and EPS of $1.32. He said expenses rose 49%, but less than revenue, so expenses as a percentage of revenue fell from 19% to 15%; R&D expense rose 31% and SG&A rose 81% due mainly to performance-based compensation. He also noted inventories fell 6%, fixed asset purchases were $57,000 as the expansion was completed, future fixed asset spending should be significantly less, and cash plus marketable securities rose to $43.9 million.
Analysts asked how much of the revenue jump came from the completed capacity expansion versus market demand, and management said both mattered: the expansion is now being used mainly for R&D, while market conditions and strong new products are also driving sales. They were asked whether the expanded capacity will eventually move more into production, and management said production will phase over as new products ramp. Questions on new product momentum showed most volume came from existing customers, though there were new customers as well; on A/R, management said the increase was mainly due to higher sales and timing, with most late-quarter invoices already collected.
The call showed real operating leverage: revenue growth far outpaced expense growth, margins were very strong, and the balance sheet strengthened even after dividends. Management sounded increasingly confident that robotics, automation, AIoT, and new medical sensors can support a higher growth profile over time.
Management still declined to provide formal guidance or confirm that the quarter establishes a permanently higher revenue run rate. The call also showed dependence on a few high-growth end markets and large customers, and the revenue spike was partly attributed to timing and a stronger semiconductor environment rather than purely sustained volume expansion.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.0%
- Shares Outstanding
- 4.84M
- Float Shares
- 4.79M
of shares held by institutions
123 13F filers
Buy/sell ratio 0.92. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Penserra Capital Management LLC | 635.27K | ▲ 54.77K |
| Blackrock, Inc. | 423.55K | ▲ 52.48K |
| Vanguard Group Inc | 404.28K | ▼ 69 |
| State Street Corp | 375.04K | ▲ 192.67K |
| Vanguard Capital Management LLC | 215.60K | ▲ 5.10K |
| Renaissance Technologies LLC | 170.73K | ▼ 2.87K |
| Geode Capital Management, LLC | 157.11K | ▲ 11.85K |
| Ranger Investment Management, L.P. | 121.34K | ▲ 1.17K |
| Dimensional Fund Advisors LP | 109.02K | ▲ 10.44K |
| Punch & Associates Investment Management, Inc. | 81.22K | ▼ 22.35K |
| Royce & Associates LP | 80.37K | ▼ 148.93K |
| Two Sigma Investments, LP | 76.38K | ▼ 3.23K |
Held by 168 ETFs
Biggest fund positions in NVEC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 12, 26 | Wei Xuan Kelly | sell | 538 |
| Aug 17, 26 | BAKER DANIEL A | sell | 1,500 |
| Aug 6, 26 | Valentine Carolyn Walker | other | 1,000 |
| Aug 6, 26 | Wei Xuan Kelly | other | 1,000 |
| Aug 6, 26 | HOLLISTER PATRICIA M | other | 1,000 |
| Aug 6, 26 | BRACKE JAMES W | other | 1,000 |
| Jul 27, 26 | BAKER DANIEL A | other | 1,061 |
| Jul 27, 26 | BAKER DANIEL A | other | 757 |
| Jul 27, 26 | BAKER DANIEL A | sell | 1,518 |
| Jul 27, 26 | BAKER DANIEL A | other | 864 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NVEC coverage
Recent articles, reports, and earnings notes.
No research on NVEC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVEC report →NVE Corp (NVEC) Shares Surge 4.8% -- What GF Score of 68 Tells Investors
gurufocus.com · Aug 12
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
benzinga.com · Aug 1
NVE Corp Q1 Earnings Surge Y/Y on Strong Sales & New Products
zacks.com · Jul 24
NVE Corporation: I Missed The Breakout, And I'm Still Waiting
seekingalpha.com · Jul 23
NVE Corporation (NVEC) Q1 2027 Earnings Call Transcript
seekingalpha.com · Jul 22
NVE Q1 Earnings Call Highlights
marketbeat.com · Jul 22
NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend
businesswire.com · Jul 22
NVE Corporation Announces CEO Transition and Board Expansion
businesswire.com · Jun 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.